Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Pulse Biosciences (PLSE) Gross Profit (2021 - 2025)

Pulse Biosciences has reported Gross Profit over the past 3 years, most recently at -$193000.0 for Q3 2025.

  • Quarterly results put Gross Profit at -$193000.0 for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was -$193000.0 (changed N/A YoY), and the annual figure for FY2022 was -$11.2 million, down 1879.58%.
  • Gross Profit for Q3 2025 was -$193000.0 at Pulse Biosciences, up from -$1.3 million in the prior quarter.
  • Over the last five years, Gross Profit for PLSE hit a ceiling of -$153000.0 in Q3 2021 and a floor of -$8.4 million in Q3 2022.
  • Median Gross Profit over the past 3 years was -$509000.0 (2022), compared with a mean of -$1.7 million.
  • Peak annual rise in Gross Profit hit 211.08% in 2022, while the deepest fall reached 5390.2% in 2022.
  • Pulse Biosciences' Gross Profit stood at -$415000.0 in 2021, then tumbled by 211.08% to -$1.3 million in 2022, then soared by 85.05% to -$193000.0 in 2025.
  • The last three reported values for Gross Profit were -$193000.0 (Q3 2025), -$1.3 million (Q4 2022), and -$8.4 million (Q3 2022) per Business Quant data.